Joint ATS/CHEST Comments to CMS on ICD-10 Codes | October 14, 2022
CHEST and the American Thoracic Society sent comments to the Centers for Medicare & Medicaid Services on coding proposals to be considered at the March 2023 ICD-10 Coordination and Maintenance Committee meeting, including proposals related to intubated prone positioning, bronchiolitis obliterans syndrome, and social determinants of health.
AMA Sign-on Letter Regarding Medicare Physician Payments | September 22, 2022
CHEST signed onto a letter from the American Medical Association and dozens of other medical societies expressing concerns about the mounting financial instability of the Medicare physician payment system.
Letter to CMS on CY 2023 HOPPS | September 12, 2022
CHEST joined the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Association for Respiratory Care, and the American Thoracic Society to comment on payment changes to pulmonary rehabilitation programs.
Letter to CMS on CY 2023 Physician Fee Schedule | August 24, 2022
CHEST joined several pulmonary organizations and patient advocacy groups to comment on the safety and effectiveness of direct supervision through virtual presence as it relates to cardiac and pulmonary rehabilitation programs.
ICD-10 Code for Prone Positioning | June 10, 2022
CHEST and nine other groups submitted a letter to the US House of Representatives and the Senate voicing the critical need to prioritize the immunocompromised population as additional COVID-19 relief funds are considered.
ICD-10 Code for Sepsis Aftercare | June 7, 2022
CHEST, along with other members of the Critical Care Societies Collaborative, sent a letter strongly supporting a proposal for a new ICD-10-CM code, "Z51.2 – Encounter for Sepsis Aftercare." The societies noted that this code will improve public health by identifying a growing population of sepsis survivors and facilitating provision of relevant clinical services to reduce the well-known, health-related risks in postacute care settings.
SEP-1 protocol to manage severe sepsis and septic shock | April 25, 2022
Based on a long-standing commitment to reducing death and disability resulting from delayed early sepsis care, CHEST, together with the Society for Critical Care Medicine, issued a letter to the National Quality Forum regarding #0500 (SEP-1) measure - Severe Sepsis and Septic Shock: Management Bundle.
CMS urged to rescind APP split/shared policy | April 11, 2022
A letter to the Centers for Medicare & Medicaid Services requests that the agency not move forward with the billing policy updates to split/shared visits (between physicians and advanced practice providers) set to take effect in 2023.
Request to extend telehealth services issued to Congress | March 10, 2022
A letter to members of Congress urges expanded telehealth services as a method of health care delivery that may enhance the patient-physician relationship, improve health outcomes, increase access to care, and reduce medical costs when used as a component of a patient's longitudinal care.
CHEST asks Congress to extend a 3.75% Medicare Physician Fee Schedule payment adjustment | December 9, 2021
CHEST and 280 other state and national associations came together to ask members of Congress to extend a 3.75% Medicare Physician Fee Schedule payment adjustment through calendar year 2022.
CHEST and ATS advocate for Medicare physician fees to improve access to care | September 20, 2021
In response to the 2022 Physician Fee Schedule proposed by the Centers for Medicare and Medicaid Services, the Joint Clinical Practice Committee, comprised of leaders from the CHEST and the American Thoracic Society, formally submitted comments and suggested edits to the proposal.
Joint CHEST/ATS Comments to CMS on Proposed 2021 Medicare Physician Fee Schedule | October 5, 2020
CHEST and ATS submitted comments to help CMS craft the final 2021 Medicare Physician Fee Schedule rule.
Position Statement for Coverage and Payment for Bronchial Thermoplasty | May 12, 2014
Bronchial thermoplasty offers treatment for patients with severe asthma who continue to be symptomatic despite maximal medical treatment. We believe the literature supports bronchial thermoplasty as a therapeutic option for patients with severe asthma.